Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Pre-pandemic SARS-CoV-2 potential natural immunity among population of the Democratic Republic of Congo

View ORCID ProfileMarc Souris, Léon Tshilolo, View ORCID ProfileDaniel Parzy, View ORCID ProfileRachel Kamgaing, Destin Mbongi, Baltazar Phoba, Marie-Anasthasie Tshilolo, René Mbungu, View ORCID ProfilePierre Morand, View ORCID ProfileJean-Paul Gonzalez
doi: https://doi.org/10.1101/2021.04.28.21256243
Marc Souris
1UMR Unité des Virus Émergents (UVE Aix-Marseille Univ-IRD 190-Inserm 1207), Marseille 13005 France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marc Souris
  • For correspondence: marc.souris@ird.fr
Léon Tshilolo
2Centre Hospitalier Mère-Enfant Monkole, Kinshasa, RD Congo
3Centre de Formation et d’Appui Sanitaire (CEFA), Mont-Ngafula, Kinshasa. BP 817 - RD Congo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Parzy
4Defideva/Altadeva – Biological Lab, Luminy Biotech, Marseille 13009 France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Parzy
Rachel Kamgaing
5Centre International de Reference Chantal Biya (CIRCB), Yaoundé, Cameroon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rachel Kamgaing
Destin Mbongi
3Centre de Formation et d’Appui Sanitaire (CEFA), Mont-Ngafula, Kinshasa. BP 817 - RD Congo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baltazar Phoba
3Centre de Formation et d’Appui Sanitaire (CEFA), Mont-Ngafula, Kinshasa. BP 817 - RD Congo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Anasthasie Tshilolo
3Centre de Formation et d’Appui Sanitaire (CEFA), Mont-Ngafula, Kinshasa. BP 817 - RD Congo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
René Mbungu
3Centre de Formation et d’Appui Sanitaire (CEFA), Mont-Ngafula, Kinshasa. BP 817 - RD Congo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Morand
6UMI « Résiliences » (IRD-CIRES), Bondy 93143 France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pierre Morand
Jean-Paul Gonzalez
7School of Medicine, Georgetown University, Department of Microbiology & Immunology, Washington, DC 20057 USA. Centaurus Biotech LLC, Vienna, VA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jean-Paul Gonzalez
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

More than a year after the emergence of COVID-19, significant regional differences in terms of morbidity persist, showing lower incidence rates in sub-Saharan Africa, Southeast Asia, and Oceania. Like SARS-CoV-1 and MERS viruses, SARS-CoV-2 is monophyletically positioned with parental species of chiropteran coronavirus. Furthermore, we observe that the spatial distribution of several targeted bat species (i.e., Coronavirus species hosts) overlaps the distribution of countries with low COVID-19 incidence.

The work presented here aims to test the presence of natural immunity among population with a low COVD-19 prevalence, potentially due to a previous exposure to coronavirus antigens of a virus close related to SARS-CoV-2. To identify such pre-existing immunity, an ELISA serological test was used to detect IgG antibodies targeting main SARS-CoV-2 proteins including: the N-protein, the Spike 1 (S1) protein, the receptor binding domain (RBD) of the S1 protein, the N-terminal domain (NTD) of the S1 protein, and the S2 protein.

A total of 574 sera samples collected before 2019 in the population of the Democratic Republic of Congo (DRC) were tested). 189 control sera from blood donors in France were used as control samples.

The results showed a statistically significant difference between the DRC samples and control samples for all antigens (N, S1, S2, NTD) except for RBD. The percentage of positive samples presenting reactive antibodies for S1 antigen was respectively of 19.2% for RDC versus 2.11% for the control, and of 9.3% versus 1.6% for the S2 antigen.

In conclusion, our data showed that the study population has been potentially exposed to a SARS-CoV-2-like virus antigen before the pandemic in the Central African sub-region. Therefore, it is quite legitimate to think that this prior immunity may be protective and responsible for the observed low prevalence of COVID-19. Moreover, we can assume that this not yet identified SARS-CoV-2-like could be associated to a chiropteran species in close contact with the studied population. In order to confirm the presence of SARS-CoV-2-like virus antibodies and ultimately identify the neutralizing potential for the detected antibodies, our study is underway in other African and Asian countries, where the COVID-19 prevalence is limited.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Fond de crise COVID-19, IRD (Institut de Recherche pour le Developpement), Marseille, France

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval was obtained from the Ethics Committee of the Centre de Formation et d'Appui Sanitaire/Centre Hospitalier Monkole (N/Ref: 01/CEFAMONKOLE/CEL/2013).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Funding “Fond de crise COVID-19”, IRD (Institut de Recherche pour le Développement), Marseille, France

Data Availability

N/A

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 01, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Pre-pandemic SARS-CoV-2 potential natural immunity among population of the Democratic Republic of Congo
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Pre-pandemic SARS-CoV-2 potential natural immunity among population of the Democratic Republic of Congo
Marc Souris, Léon Tshilolo, Daniel Parzy, Rachel Kamgaing, Destin Mbongi, Baltazar Phoba, Marie-Anasthasie Tshilolo, René Mbungu, Pierre Morand, Jean-Paul Gonzalez
medRxiv 2021.04.28.21256243; doi: https://doi.org/10.1101/2021.04.28.21256243
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Pre-pandemic SARS-CoV-2 potential natural immunity among population of the Democratic Republic of Congo
Marc Souris, Léon Tshilolo, Daniel Parzy, Rachel Kamgaing, Destin Mbongi, Baltazar Phoba, Marie-Anasthasie Tshilolo, René Mbungu, Pierre Morand, Jean-Paul Gonzalez
medRxiv 2021.04.28.21256243; doi: https://doi.org/10.1101/2021.04.28.21256243

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (504)
  • Anesthesia (110)
  • Cardiovascular Medicine (1238)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (531)
  • Epidemiology (10020)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2452)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1642)
  • Health Policy (752)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (533)
  • Infectious Diseases (except HIV/AIDS) (11864)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (252)
  • Medical Ethics (74)
  • Nephrology (268)
  • Neurology (2280)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (536)
  • Oncology (1245)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (157)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (730)
  • Pharmacology and Therapeutics (312)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4832)
  • Radiology and Imaging (837)
  • Rehabilitation Medicine and Physical Therapy (491)
  • Respiratory Medicine (651)
  • Rheumatology (285)
  • Sexual and Reproductive Health (238)
  • Sports Medicine (227)
  • Surgery (267)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)